Germany· DE-A57-aaaf20a72abd97e9

Cinacalcet Al

A cinacalcet product containing cinacalcet, registered in Germany by Aliud Pharma Gmbh. The same ATC class is registered in 19 of our 19 countries.

ATC H05BX01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCinacalcet AlATCH05BX01REGISTER NO.DE-A57-aaaf20a72abd97…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Cinacalcet is registered in 19 of 19 countries.

Countries holding a registration under ATC H05BX01 (cinacalcet), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 11 of them publish a price we can compare per daily dose

Cinacalcet · ATC H05BX01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cinacalcet costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $1.87 in Italy to $9.84 in Switzerland — a ×5.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cinacalcet · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$9.84
  • FR France$5.46
  • IT Italy$1.87
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Cinacalcet
Manufacturer
Aliud Pharma Gmbh
Country
Germany (DE)
ATC code
H05BX01
ATC class
Cinacalcet
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

284 interactions on record for cinacalcet.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cinacalcet · interactions on record

284 records

  • 14 severe
  • 125 moderate
  • 3 minor
  • 142 info

Most severe, free to view

  • EliglustatA16AX10severe
  • EtelcalcetideH05BX04severe
  • TamoxifenL02BA01severe
  • OliceridineN02AX07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cinacalcet in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinacalcet products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Cinacalcet Medice, Cinacalcet Pharmsol
  • Belgium · Cinacalcet Ab
  • Bulgaria · Синакалцет Тева, Синакалцет Хитън
  • Cyprus · Cinacalcet (Ωσ Hydrochloride) Pharmazac, Cinacalcet Rafarm
  • Czechia · Cinacalcet Heaton, Cinacalcet Stada
  • Denmark · Cinacalcet Amarox, Cinacalcet Glenmark
  • Spain · Cinacalcet Abdi, Cinacalcet Aurovitas
  • Finland · Cinacalcet Accord, Cinacalcet Orion
  • France · Cinacalcet Arrow, Cinacalcet Bgr
  • United Kingdom (Northern Ireland) · Cinacalcet Abdi, Cinacalcet Amarox
  • Greece · Calcedem, Cinacalcet Faran
  • Hungary · Cinacalcet Onkogen
  • Ireland · Cinacalcet Clonmel, Cinacalcet Teva
  • Iceland · Cinacalcet Accordpharma, Cinacalcet Stada
  • Italy · Cinacalcet Abdi, Cinacalcet Aurobindo
  • Liechtenstein · Cinacalcet Accordpharma, Cinacalcet Viatris
  • Malta · Cinacalcet Clonmel, Cinacalcet Heaton
  • Netherlands · Calcedem, Cinacalcet Abdi
  • Norway · Cinacalcet, Cinacalcet Accordpharma
  • Poland · Cinacalcet Aurovitas
  • Portugal · Cinacalcet Basi, Cinacalcet Generis
  • Romania · Cinacalcet Heaton
  • Sweden · Cinacalcet Amarox, Cinacalcet Glenmark
  • Slovakia · Cinacalcet Heaton, Cinacalcet Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8d431f8-2e84-43e4-96ba-86cedf15e725
GET /v1/drugs/d8d431f8-2e84-43e4-96ba-86cedf15e725?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Cinacalcet",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about cinacalcet.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.